The C/EBP-β-SOD2 signaling pathway is pivotal in PTE-mediated eradication of quiescent PCa cells during reactivation and represents a promising therapeutic target for preventing PCa recurrence. This evidence concerns the gene CEBPB and posterior cortical atrophy.